News | Пацієнти України - Part 3

News

Home > News
29/09/2016

Open data on leftovers of medicines procured by the State ruined the corruption schemes in Odesa Oblast

More than 20 thousand citizens of Odesa Oblast used the services of web-site liky.odesa.ua where data on leftovers of medicines, which are procured at public expenses and can be received by patients free  of charge, are opened. This anti-corruption initiative was presented by the Executive director of CF “Patients of Ukraine” Olga Stefanyshyna during the contest “Stop corruption: public action in the Odesa region.”
19/09/2016

Activists Pressed Government for Increase of Budget on Medicines Procurement by UAH 2 Billion

Seriously ill patients will receive far more medicines in 2017.  Draft Budget-2017 allocates UAH 5,9 billion for procurement of medicines for patients with HIV, TB, viral hepatitis, pediatric and adult oncology, haemophilia and other diseases, which is by UAH 2 billion more than in the previous year.  Corresponding draft law  is registered at the Verkhovna Rada website.
15/09/2016

Bohatyreva’s Team Filed a Case against Activists

Today representatives of the patient and anti-corruption organizations have organized a protest action in front of the Podolsk district court demanding to close the case and stop placing pressure on the activists. The fact is that “Bohatyreva’s witnesses”, people who worked with her at the MoH and dealt with procurement of medicine, filed a case against the teams of CF “Patients of Ukraine” and the Anti-Corruption Action Center.
07/09/2016

The Government will look for funding to treat seriously-ill patients

The Government will look for additional funds in Budget 2017 to procure medicines for seriously-ill patients. Such decision was made yesterday during the meeting of patients’ organizations activists with the Minister of Finance Olexander Danylyuk and the acting Minister of Health Uliana Suprun.
01/09/2016

Patients’ organizations have learnt how to use advocacy and PR tools effectively

Non-governmental organizations have learnt how to use advocacy and PR tools effectively in order to achieve socially important for patients goals. On August 30-31, 2016 the CF “Patients of Ukraine” conducted under the USAID “Cost(less) Medicine” Project training aimed at capacity building of NGOs.
01/09/2016

HOW MUCH UKRAINIANS PAY FOR MEDICINES IN FACT — RESEARCH

Research measuring the share of household budget, which an average-sized Ukrainian family spends for medicines, has been launched in Ukraine. The research is performed under the Cost(less) Medicine Project funded by the U.S. Agency for International Development (USAID) and implemented by the Charitable Foundation “Patients of Ukraine”.
28/07/2016

Next year Ukrainian patients with hepatitis C may stay without treatment

As soon as next year Ukraine will not provide treatment for patients with hepatitis C for the public funds. The State Program on prevention, diagnosis and treatment of viral hepatitis for 2013-2016 ends this year. If the Cabinet of Ministers fails to continue this State Program, treatment of hepatitis will become unavailable for the Ukrainian patients.
08/07/2016

This year medicines procurements will be transferred to international organizations by July 20, 2016

The Ministry of Health will form and submit the current year budget for the procurement of medicines and medicinal products to international organizations by 20-th of July.
23/06/2016

UNDP saved for Ukraine USD 330 000 during anti-tuberculosis medicines procurement in compare with the MOH pricing 2014

United Nations Development Programme which procures drugs for the Ministry of Health has purchased up medicines for multidrug-resistant tuberculosis 3 times cheaper in compare with the MOH pricing 2014.
21/06/2016

UNDP saved for Ukraine on hepatitis medicines USD 1 million over the Ministry of Health pricing

UNDP saved for Ukraine on medicines for hepatitis nearly USD 1 million over the Ministry of Health pricing. Total savings on medicines procurement made up USD 919 000, in particular 35% of medicines are procured under the program of treatment of hepatitis in children and 21% of medicines — under the adult treatment program.